glp-1 anesthesia guidelines AAOMS may update guide for receptor agonist users A narrative review of glucagon-like

Diammonium glycyrrhizinate ameliorates portal hypertension by regulating portal macrophage oxidation and superoxide dismutase 3

Given the rising prevalence of iodine excess, it is crucial to raise awareness and implement proactive measures to prevent it from escalating into a major public health crisis in the future

DSIP Safety and Product-Quality Uncertainties Small intravenous studies cannot define the safety of repeated commercial research-product exposure

Waiting more than 60 minutes extends the fasting period unnecessarily without additional bioavailability benefit

Dizziness is a recognised adverse reaction listed in the Summary of Product Characteristics for several GLP-1 medications